U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07759947) titled 'Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy' on Aug. 07.
Brief Summary: The goal of this study is to demonstrate the efficacy of an evidence-based, small-group, telehealth intervention ('STRIDE') for improving patients' ability to cope with side effects from adjuvant endocrine therapy (AET) and adhere to AET medication regimens for patients with hormone-sensitive breast cancer.
Study Start Date: Feb. 01, 2027
Study Type: INTERVENTIONAL
Condition:
Hormone Receptor Positive Breast Cancer
Intervention:
BEHAVIORAL: STRIDE
STRIDE is a 6-session patient-directed cognitive behavioral th...